Plain-English translation of NCT07302230 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The EMPOWER trial is testing whether a personalized home exercise program delivered through a digital app called ExerciseRx™ can help people with non-muscle invasive bladder cancer increase their physical activity. You would be randomly assigned to either follow standard physical activity recommendations with educational materials, or to complete guided 20–30 minute exercise sessions four times per week for 12 weeks using the app on your smartphone. Both groups wear a fitness tracker to monitor activity throughout the study.
People treated for early-stage bladder cancer often become less physically active during and after treatment, which can affect their overall health and quality of life. This trial aims to see whether a structured, home-based exercise program using technology can make it easier for patients to stay active and meet health guidelines.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly placed into one of two groups. One group receives written physical activity guidelines and wears a fitness tracker. The other group completes guided exercise sessions through the app four times a week for 12 weeks, receives personalized daily step goals that gradually increase, and also wears a fitness tracker. Both groups are followed for a check-in four weeks after the 12-week program ends. The study takes place at home using your own smartphone.
AI-generated summary from trial data · Jul 11, 2026 · Not medical advice
United States